Why Rare Disease Patient Recruitment Demands a Different Approach
Rare disease recruitment rarely fits a standard site-led model. Eligible patients are few, distributed across wide geographies and often managed outside major research centers. Many patients have long diagnostic histories, and variable diagnostic quality drives screen failures that burn weeks of site time.
Enrollment remains a major gating factor even as rare disease pipelines expand. Opening sites and waiting for referrals is not a plan.
Patiro’s Approach to Rare Disease Patient Recruitment
Patiro starts before site activation. We map where patients are actually diagnosed and treated, then build recruitment around real referral routes. We work with registries and community touchpoints to find likely candidates, including patients not yet connected to an expert center.
Advocacy partnerships are not a branding exercise. They are trust intermediaries that shape whether families engage at all. We keep outreach plain and specific, with clear expectations on eligibility, visits, and support.
Travel and visit burden can decide enrollment in rare disease. When the protocol supports it, we add telehealth touchpoints, local lab options, and home visits to keep distance from becoming an exclusion criterion.
Patiro's Expertise in Rare Disease Patient Recruitment
We run feasibility based on real patient pathways, not assumptions. You get clear inputs on investigator density, referral routes, and likely screen failure drivers before budgets and timelines lock.
We work with organizations and local advocacy groups to reach patients through channels they already trust. Prior work includes Myasthenia Gravis, Small Fiber Neuropathy, and MDS among others including cross-border and cross-continental studies.
Patiro supports travel coordination, in-home nursing when appropriate, and genetic testing logistics when confirmation is part of eligibility. We also plan for cross-border participation when the nearest expert site is in a neighboring country.
Why Partner With Patiro for Your Rare Disease Patient Recruitment?
Patiro brings 10+ years of rare disease and complex indication recruitment experience, supported by a global medical team and local execution.
We use digital pre-screeners tied to key inclusion and exclusion criteria before a site ever invests time. When protocols allow it, we plan re-screening workflows so patients are not lost due to temporary lab values, timing windows, or correctable documentation gaps.
We support full-service and tailored FSP models for recruitment and site support. Patiro also offers Pay Only per Enrolled Patient pricing, so spend tracks enrollments rather than activity volume.
Schedule a call with our team to discuss how we can help you with your rare disease trial
Frequently Asked Questions
Does Patiro support cross-border enrollment in Europe or other regions?
Yes. We plan cross-border logistics and enrollment pathways, including practical travel support and country-level coordination.
How does Patiro reduce screen failures in rare disease trials where misdiagnosis is common?
We use digital pre-screeners aligned to protocol criteria before referral to sites. When possible, we design re-screening paths to keep viable patients progressing through the protocol.
Can Patiro manage genetic testing logistics and counseling workflows?
Yes. We support genetic testing logistics and participant communication workflows when genetic confirmation is required for eligibility.
How does Patiro build trust with patients who are skeptical of clinical research?
We work through advocacy partners, keep messaging direct, and set expectations early. Trust comes from transparency, burden reduction, and consistent support during participation.
How does pricing work?
Patiro offers a pay-per-enrolled-patient model, meaning sponsors pay for enrolled participants rather than referral volume. This keeps budget risk low and aligns Patiro's incentives directly with the sponsor's enrollment goals.
How fast can you start rare disease patient recruitment?
Launch timing depends on protocol clarity, geographies, and the site plan. Patiro can mobilise quickly once pre-screening and referral pathways are confirmed. With experience supporting rescue studies where enrollment had already fallen behind, Patiro knows how to move fast without compromising referral quality
